Rosuvastatin in the management of hyperlipidemia
JWM Cheng - Clinical therapeutics, 2004 - Elsevier
BACKGROUND:: Rosuvastatin is a new statin indicated to reduce elevated levels of total
cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides and to increase …
cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides and to increase …
Effectiveness of atorvastatin in treating patients to LDL-C goals compared with lovastatin, pravastatin and simvastatin
J Nawrocki, L Shurzinske, DM Black - Atherosclerosis, 1997 - elibrary.ru
The efficacy of atorvastatin has been compared with lovastatin, pravastatin and simvastatin
in three large multicenter trials. Atorvastatin at its starting dose of 10 mg/day provided …
in three large multicenter trials. Atorvastatin at its starting dose of 10 mg/day provided …
The MERCURY II trial: benefits of rosuvastatin
L Izzat - The British Journal of Diabetes & Vascular Disease, 2006 - journals.sagepub.com
Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapy (MERCURY II)
was a 16-week, randomised, open-label study in high-risk subjects with primary …
was a 16-week, randomised, open-label study in high-risk subjects with primary …
Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: Results from the VOYAGER meta-analysis
BW Karlson, MK Palmer, SJ Nicholls… - European journal of …, 2016 - journals.sagepub.com
Background Achieving the greatest reduction in atherogenic lipoproteins requires the
optimum dose and potency of statin. Using data from the VOYAGER meta-analysis, we …
optimum dose and potency of statin. Using data from the VOYAGER meta-analysis, we …
[引用][C] Achievement of the Joint European Societies LDL-cholesterol goal by hypercholesterolaemic patients receiving rosuvastatin, pravastatin or simvastatin
R Paoletti, L Pisciotta, H Southworth, I Carbarns - Atherosclerosis Suppl, 2002
More Western hypercholesterolemic patients achieve Japan Atherosclerosis Society LDL-C goals with rosuvastatin therapy than with atorvastatin, pravastatin, or …
K Strutt, R Caplan, H Hutchison, A Dane… - Circulation …, 2004 - jstage.jst.go.jp
Background Data from Western comparative trials suggest that rosuvastatin is more effective
than atorvastatin, simvastatin, and pravastatin in helping hypercholesterolemic patients …
than atorvastatin, simvastatin, and pravastatin in helping hypercholesterolemic patients …
Expanding options with a wider range of rosuvastatin doses
AG Olsson - Clinical therapeutics, 2006 - Elsevier
BACKGROUND:: The dose range for rosuvastatin in Europe has recently been expanded to
5 to 40 mg and is now in line with the dose range currently available in the United States …
5 to 40 mg and is now in line with the dose range currently available in the United States …
Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol
L Zhang, S Zhang, Y Yu - Herz, 2020 - search.proquest.com
Background The VOYAGER meta-analysis reported on the low-density lipoprotein
cholesterol (LDL-C)-lowering effect of commonly used statins in Caucasian subjects. As …
cholesterol (LDL-C)-lowering effect of commonly used statins in Caucasian subjects. As …
Comparison of efficacy and safety after administering high potency statin to high risk patients: rosuvastatin 10 mg versus atorvastatin 20 mg
KH Yun, HY Park, JH Choi, MJ Song… - Korean Circulation …, 2007 - synapse.koreamed.org
Background and Objectives Although the rate of prescribing hydroxylmethyglutaryl-CoA
reductase inhibitors (statin) has recently increased, there is a large treatment gap between …
reductase inhibitors (statin) has recently increased, there is a large treatment gap between …